
Radiotracer access gaps narrow after copper-64 adoption
A JACR study found that gallium-68 PET radiotracer adoption widened rural access gaps for neuroendocrine tumor imaging, while copper-64 DOTATATE later reduced those differences.
Section
Every story we've published, newest first. 296 articles.

A JACR study found that gallium-68 PET radiotracer adoption widened rural access gaps for neuroendocrine tumor imaging, while copper-64 DOTATATE later reduced those differences.

A phase 2 DETECT study found that 99mTc-maraciclatide SPECT/CT imaging was concordant with surgical findings in 16 of 19 participants with suspected or confirmed endometriosis.

AIIMS New Delhi has begun routine clinical use of Hyperfine’s Swoop portable MRI system. The deployment marks India’s first bedside MRI system for routine clinical brain imaging.

C-Ray Therapeutics received FDA active status for its Type II Drug Master File for copper-64 chloride. The filing can now be referenced by radiopharmaceutical developers in IND and NDA submissions.

Calidar completed enrollment in a first-in-human study of its investigational 4D Mammography system at Baptist Health Hardin. The trial enrolled 61 patients and will now move into data analysis.

Azra AI has acquired Thynk Health, a lung cancer screening and incidental findings management company. The combined platform will support imaging-driven care coordination from detection through diagnosis, treatment, and survivorship.

Aidoc said the round was led by Growth Equity at Goldman Sachs Alternatives and brings its total funding to more than $500M. The company plans to expand its CARE foundation model, aiOS enterprise platform, and automated imaging-report capabilities.

Avatar Medical received FDA 510(k) clearance for Avatar Medical Vision, a software platform for 3D CT and MR image processing, review, and surgical planning across standard displays, glasses-free 3D, and VR.

ASTRO members visited Capitol Hill to urge action on Medicare radiation therapy cuts, ROCR payment reform, and prior-authorization legislation affecting cancer care access.

Australia’s Professional Services Review said an unnamed diagnostic radiologist agreed to repay $3.6M after concerns over high-volume Medicare billing, altered requests, unclear supervision, and inadequate records.